Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Disease to Soft Tissue”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03359018
What this trial is testing

Apatinib Plus Anti-PD1 Therapy for Advanced Osteosarcoma

Who this might be right for
Progression-free SurvivalOverall SurvivalClinical Benefit Rate+1 more
Peking University People's Hospital 43
Early research (Phase 1)Ended earlyNCT03604783
What this trial is testing

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsSarcomaEwing Sarcoma+2 more
Sumitomo Pharma America, Inc. 74
Not applicableStudy completedNCT00132704
What this trial is testing

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

Who this might be right for
Ovarian NeoplasmsColorectal NeoplasmsMelanoma+2 more
Memorial Sloan Kettering Cancer Center 149
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)WithdrawnNCT02342600
What this trial is testing

SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)

Who this might be right for
Gastrointestinal Stromal Tumors
Sarcoma Alliance for Research through Collaboration
Testing effectiveness (Phase 2)Looking for participantsNCT06498648
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

Who this might be right for
Advanced Dedifferentiated LiposarcomaAdvanced LeiomyosarcomaAdvanced Soft Tissue Sarcoma+5 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Study completedNCT02607332
What this trial is testing

Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 25
Early research (Phase 1)Looking for participantsNCT06910657
What this trial is testing

IDOV-Immune for Advanced Solid Tumors

Who this might be right for
Colorectal CancerPancreatic CancerMelanoma+13 more
ViroMissile, Inc. 78
Early research (Phase 1)Ended earlyNCT01313429
What this trial is testing

Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum

Who this might be right for
SarcomaMelanomaEpithelial Malignancies+1 more
National Cancer Institute (NCI) 19
Not applicableUnknownNCT03375437
What this trial is testing

RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.

Who this might be right for
Soft Tissue SarcomaAdvanced CancerMetastatic Cancer
Centre Leon Berard 376
Early research (Phase 1)Study completedNCT05114668
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumor, Adult
Kazia Therapeutics Limited 32
Testing effectiveness (Phase 2)Study completedNCT01692496
What this trial is testing

Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial

Who this might be right for
Advanced and / or Metastatic Liposarcoma
Grupo Espanol de Investigacion en Sarcomas 52
Early research (Phase 1)Active Not RecruitingNCT03132922
What this trial is testing

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Who this might be right for
Urinary Bladder CancerMelanomaHead and Neck Cancer+7 more
USWM CT, LLC 71
Testing effectiveness (Phase 2)UnknownNCT03171389
What this trial is testing

POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST

Who this might be right for
GIST, MalignantKIT Exon 13 MutationKIT Gene Mutation
Sebastian Bauer 81
Testing effectiveness (Phase 2)Ended earlyNCT03601897
What this trial is testing

A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor
Deciphera Pharmaceuticals, LLC 177
Post-approval studies (Phase 4)Study completedNCT04145518
What this trial is testing

Mechanistic Characterization of Uterine Pain

Who this might be right for
Dysmenorrhea (Disorder)Dysmenorrhea PrimaryDysmenorrhea Secondary+3 more
Endeavor Health 183
Testing effectiveness (Phase 2)UnknownNCT00290485
What this trial is testing

Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Maisonneuve-Rosemont Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06772233
What this trial is testing

Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment

Who this might be right for
Metastatic Gastrointestinal Stromal Tumors (GIST)
Peking University 100
Large-scale testing (Phase 3)Temporarily pausedNCT05691478
What this trial is testing

Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Who this might be right for
High Grade OsteosarcomaLocalized OsteosarcomaMetastatic Osteosarcoma+1 more
National Cancer Institute (NCI) 1,122
Testing effectiveness (Phase 2)Looking for participantsNCT03707808
What this trial is testing

Intratumoral Injection of Autologous CD1c (BDCA-1)+ MyDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab

Who this might be right for
Solid TumorMetastases to Soft Tissue
Universitair Ziekenhuis Brussel 18
Next Page